Thor Halfdanarson, Medical Oncologist at Mayo Clinic, shared a paper Markus Amman and colleagues on X:
“Liver resection in patients with high-grade neuroendocrine neoplasms, should that be considered…? Pts with G3 NET and NEC certainly have inferior outcomes but some may benefit from surgical debulking. Who are these patients? How can we better select?”
Authors: Markus Amman et al.